Ethics, let alone laws, can’t keep up with the accelerating pace of science and technology. Growth is exponential and often unexpected, and different nations have varying rules of engagement. It’s difficult to come up with any universal policy. Biotech, in particular, will be messy and dangerous. From a post about the implications of synthetic yeast by Julian Savulescu at Practical Ethics:
“Back in 2010, I blogged about Craig Venter’s creation of the first synthetic organism, Synthia, a bacteria.
Now, in 2014, the next step has been made by a team at John Hopkins University, the use of synthetic biology in yeast, which, whilst still a simple organism, has a similar cell structure to humans (and other more complex organisms): a nuclei, chromosomes and organelles. The engineered yeast has been reproduced to over 100 generations, passing on its new DNA.
The pace is breathtaking. Moore’s law describes a phenomenon in computing, where computer capacity (so far) doubles every two years. Kurzweil uses Moore’s law to predict the: a state where humans no longer control, or even comprehend, the progress that technology continues to make.
It’s difficult to measure scientific progress in the same way as computer power, but it’s clear that leaps in progress are now measured in years, not decades. Yet still we wait until technology is upon us before we act.
Consider a parallel technology: cloning. The earliest intimations of cloning were perhaps in 1885, when Hans Dreisch successfully divided sea urchin embryos. Yet it was not until Dolly the sheep was cloned in 1998 that we began to become concerned and consider deeply thoughts on human cloning. A moratorium on human cloning research was put in place in the US, and a ban in Europe. In industry, cloned animals are used in farming already, yet the EC and UK governments are apparently at loggerheads about whether to allow this to continue.
Synthetic biology, I believe, has far greater potential than straight forward cloning. But this potential includes great harms as well as great benefits.“
Tags: Craig Venter, Julian Savulescu